| 000 | 01476 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513232317.0 | ||
| 264 | 0 | _c20010329 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0300-8916 | ||
| 024 | 7 |
_a10.1177/030089160008600605 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMans, D R | |
| 245 | 0 | 0 |
_aCellular and clinical pharmacokinetic/pharmacodynamic basis for lack of efficacy of 21-day continuous topotecan in patients with untreated advanced adenocarcinoma of the pancreas. _h[electronic resource] |
| 260 |
_bTumori _c |
||
| 300 |
_a458-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aTopotecan _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aDi Leone, L | |
| 700 | 1 | _aFerrary Caldas, A P | |
| 700 | 1 | _aMaino, M | |
| 700 | 1 | _aAlmeida, L | |
| 700 | 1 | _aCancela, A I | |
| 700 | 1 | _aGrivicich, I | |
| 700 | 1 | _aBrondani da Rocha, A | |
| 700 | 1 | _aSchwartsmann, G | |
| 773 | 0 |
_tTumori _gvol. 86 _gno. 6 _gp. 458-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/030089160008600605 _zAvailable from publisher's website |
| 999 |
_c11156071 _d11156071 |
||